NCT00303329 Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients Status COMPLETED Phase PHASE2
NCT00301912 Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer Status WITHDRAWN Phase PHASE2
NCT00294203 Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer Status COMPLETED Phase PHASE1
NCT00286182 Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF) Status COMPLETED Phase PHASE2
NCT00285662 Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants Status COMPLETED Phase NA
NCT00283465 A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy Status COMPLETED Phase PHASE4
NCT00281892 Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE3
NCT00270283 A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy Status COMPLETED Phase PHASE2
NCT00270270 A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy Status COMPLETED Phase PHASE2
NCT00270179 A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery. Status COMPLETED Phase PHASE3
NCT00270166 The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy Status COMPLETED Phase PHASE3
NCT00270140 A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Facilitating the Presurgical Collection of Blood to be Used for Self-donation During Surgery on the Spine, Hip, or Knee. Status COMPLETED Phase PHASE3
NCT00270127 Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy Status COMPLETED Phase PHASE3
NCT00270114 A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood) Status COMPLETED Phase PHASE2/PHASE3
NCT00270101 The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma Status COMPLETED Phase PHASE3
NCT00270088 A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery. Status COMPLETED Phase PHASE3
NCT00270062 A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery. Status COMPLETED Phase PHASE3
NCT00270049 Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2